Literature DB >> 16164859

Shave excision of common acquired melanocytic nevi: cosmetic outcome, recurrences, and complications.

Lara Ferrandiz1, David Moreno-Ramirez, Francisco M Camacho.   

Abstract

BACKGROUND: Surgical treatment of benign melanocytic lesions demands the application of simple and effective surgical techniques with the possibility of performing a histopathologic examination with an acceptable cosmetic outcome. However, recurrence rates and the cosmetic result should be taken into account because the main reason for these lesions to be removed is the patient's cosmetic improvement. The present study evaluates the results obtained by shave excision of benign pigmented lesions in terms of cosmetic outcome, recurrence rates, and complications from both a subjective and an objective point of view.
MATERIAL AND METHODS: Shave excision of common acquired melanocytic nevi was performed. The patients were reviewed 3 months after surgery to evaluate the objective and subjective cosmetic results, recurrences, and postsurgical complications.
RESULTS: Over a 12-week period, 204 common acquired melanocytic nevi were shaved. Objective evaluation revealed excellent results in one-third (32.8%) of the lesions excised, with a poor result in 8.3%. The likelihood of having an imperceptible scar was significantly greater in lesions excised from the face (p < .05). Ninety-eight percent of patients (n = 192) declared that "the scar looked better than the original mole." Clinical and dermatoscopic recurrences were observed in 40 scars (19.6%). DISCUSSION: An acceptable cosmetic result, along with a low rate of recurrence, should be the aim of the surgical treatment of benign melanocytic lesions. The results obtained in this series allow us to provide more detailed and accurate information regarding the outcome and complications expected.

Entities:  

Mesh:

Year:  2005        PMID: 16164859     DOI: 10.1097/00042728-200509000-00005

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  United States Preventive Services Task Force Overstates Cosmetic Harms of Skin Cancer Screening.

Authors:  Joseph F Sobanko; Kimberly Shao; Rebecca L Pearl; Sancy Leachman
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

2.  Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.

Authors:  Agnessa Gadeliya Goodson; Scott R Florell; Kenneth M Boucher; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-12-16       Impact factor: 11.527

3.  [Treating papillomatous intradermal nevi: lasers - yes or no? A prospective study].

Authors:  S Hammes; C Raulin; S Karsai; R Bernt; H M Ockenfels
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

Review 4.  Optimal management of common acquired melanocytic nevi (moles): current perspectives.

Authors:  Kabir Sardana; Payal Chakravarty; Khushbu Goel
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-03-19

5.  "Mole removal" on Instagram Hashtags: A Cross-sectional Analysis: Nevus Treatment Methods on Instagram.

Authors:  Semih Güder; Hüsna Güder
Journal:  Dermatol Pract Concept       Date:  2022-01-01

6.  Irregularly Irregular Stellate Incisions for Selective Reduction of Benign Facial Lesions.

Authors:  David Teplica; Emmett Cooney; Jamey Srock; Michael Sayers
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.